CTLA-4 Is Expressed by Activated Mouse NK Cells and Inhibits NK Cell IFN-γ Production in Response to Mature Dendritic Cells

Abstract

NK cells express an array of activating and inhibitory receptors that determine NK cell responses upon triggering by cognate ligands. Although activating NK cell receptors recognize mainly ligands expressed by stressed, virus-infected, or transformed cells, most inhibitory receptors engage MHC class I, preventing NK cell activation in response to healthy cells. In this study, we provide insight into the regulation and function of additional receptors involved in mouse NK cell responses: CTLA-4 and CD28. CTLA-4 and CD28 engage the same ligands, B7-1 and B7-2, which are primarily expressed by APCs, such as dendritic cells. Our data demonstrate that activation of mouse NK cells with IL-2 induces the expression of CTLA-4 and upregulates CD28. CTLA-4 expression in IL-2–expanded NK cells was further up- or downregulated by IL-12 or TGF-β, respectively. Using gene-deficient NK cells, we show that CD28 induces, and CTLA-4 inhibits, IFN-γ release by NK cells upon engagement by the recombinant ligand, B7-1, or upon coculture with mature dendritic cells. Notably, we show that mouse NK cells infiltrating solid tumors express CD28 and CTLA-4 and respond to stimulation with recombinant B7-1, suggesting that the NK cell responses mediated by the CD28/CTLA-4:B7-1/B7-2 system could be of importance during malignant disease. Accordingly, our study might have implications for immunotherapy of cancer based on blocking anti–CTLA-4 mAbs.

Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model

“…CTLA-4 expression is induced on CD4 þ and CD8 þ T cells following activation and is constitutively expressed on Tregs (48). A recent study demonstrated that CTLA-4 is also expressed on NK cells upon activation and inhibits their production of IFNg (25). Together, these findings support the potential synergy between DAC and anti-CTLA-4.…”

“…6K and L), suggesting that NK cells directly execute cell killing in the context of the increased proinflammatory microenvironment. Notably, CTLA-4 was recently shown to be expressed on NK cells upon their activation and to inhibit their production of IFNg (25). Consistently, we observed that CTLA-4 blockade promotes IFNg production by NK cells.…”

Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function

“…falciparum malaria, high numbers of CD4 + T cells expressed CTLA4 and PD1 and mostly coexpressed both receptors. Although both, CTLA4 and PD1, are rapidly upregulated after T cell receptor-mediated activation, their expression can also be upregulated by alternative cytokine-based mechanisms [34, 35]. While clearly the vast majority of P .…”

NK cells and cancer: you can teach innate cells new tricks

“…Recent reports have shown that under some circumstances activated NK cells can express programmed cell death protein 1 (PD1; also known as PDCD1) 98,99 and cytotoxic T lymphocyteassociated antigen 4 (CTLA4) 100 , which are the target molecules of several US Food and Drug Administration (FDA)-approved cancer immunotherapy drugs (ipilimumab against CTLA4 and nivolumab and pembrolizumab against PD1) that restore T cell activation. A promising study showed that, in patients with multiple myeloma, NK cells express PD1 and that a PD1 antibody (CT-011) could restore NK cell-mediated antitumour activity 101 .…”